Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants?
Authors:
- Helena M. GardinerHGHelena M. Gardiner
- Christopher WrenCWChristopher Wren
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Radiofrequency catheter ablation of incessant, medically resistant supraventricular tachycardia in infants and small childrenJACC, 1992
- Supraventricular tachycardia mechanisms and their age distribution in pediatric patientsThe American Journal of Cardiology, 1992
- Clinical research on children in the 1990sJACC, 1992
- Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainideJACC, 1991
- Supraventricular tachycardia: diagnosis and current acute management.Archives of Disease in Childhood, 1991
- Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics.Heart, 1989
- Flecainide acetate for resistant arrhythmias in the young: Efficacy and pharmacokineticsJACC, 1989
- Modes of onset (“initiating events”) for paroxysmal atrial tachycardia in infants and childrenThe American Journal of Cardiology, 1986
- Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: Management and follow-upJACC, 1985
- Transesophageal study of infant supraventricular tachycardia: Electrophysiologic characteristicsThe American Journal of Cardiology, 1983